Results 91 to 100 of about 30,626 (259)

Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study) [PDF]

, 2016
Isavuconazonium sulfate (Cresemba; Astellas Pharma Inc.), a water-soluble prodrug of the triazole antifungal agent isavuconazole, is available for the treatment of invasive aspergillosis (IA) and invasive mucormycosis.
Akhtar, Shahzad, Bonate, Peter, Desai, Amit V, Hope, William W, Kovanda, Laura L, Lu, Qiaoyang, Townsend, Robert W   +6 more
core   +1 more source

Purpuric targetoid eruption revealing disseminated mucormycosis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Francisco Mano, João Teixeira
wiley   +1 more source

Safety of Rhizomucor pusillus biomass powder as a novel food pursuant to Regulation (EU) 2015/2283

EFSA Journal, Volume 23, Issue 12, December 2025.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of the Rhizomucor pusillus biomass powder as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a filamentous fungus biomass powder. The novel food is intended for use
EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Dominique Turck, Torsten Bohn, Montaña Cámara, Jacqueline Castenmiller, Stefaan De Henauw, Karen Ildico Hirsch‐Ernst, Ángeles Jos, Alexandre Maciuk, Inge Mangelsdorf, Breige Mcnulty, Androniki Naska, Kristina Pentieva, Alfonso Siani, Frank Thies, Margarita Aguilera‐Gómez, Thomas Frenzel, Marina Heinonen, Harry J. McArdle, Monika Neuhäuser‐Berthold, Peter Moldeus, Carmen Peláez, Morten Poulsen, Miguel Prieto Maradona, Josef Rudolf Schlatter, Henk van Loveren, Ermolaos Ververis, Gabriela Precup, Karen Ildico Hirsch‐Ernst   +29 more
wiley   +1 more source

Granulocyte Transfusions in Pediatric Hemato‐Oncology: Neutrophil Response and CRP Kinetics

Pediatric Blood &Cancer, Volume 72, Issue 11, November 2025.
ABSTRACT Background Granulocyte transfusions (GTXs) are used in neutropenic pediatric hemato‐oncology patients with infections unresponsive to antimicrobial therapy, but their clinical benefit remains uncertain. Methods We retrospectively reviewed all pediatric patients who received GTXs between 2013 and 2023 at a tertiary medical center.
Aviv Sever, Ron Rabinowicz, Shlomit Barzilai‐Birenboim, Salvador Fisher, Ronit Goldman Levi, Assaf Yanir, Jerry Stein, Efraim Bilavsky, Joanne Yacobovich, Vered Yahalom   +9 more
wiley   +1 more source

Subcutaneous Phycomycosis in a Child [PDF]

, 2009
Subcutaneous phycomycosis is a rare entity. We hereby report a case of subcutaneous phycomycosis in 18 months old female child who presented with a painless, non-tender swelling on the thigh.
Jagtap, SV, Naniwadekar, MR, Nikam, BP, Sanghavi, KD   +3 more
core  

Lateral Flow Assays for the Diagnosis of Invasive Aspergillosis: Current Status. [PDF]

, 2017
Purpose of reviewDiagnosis during early stages of invasive aspergillosis (IA) and targeted antifungal treatment has the potential to improve survival significantly.
Heldt, Sven, Hoenigl, Martin
core   +1 more source

Repositioning Triazoles as Phosphodiesterase‐4 Inhibitors to Suppress COVID‐19 Cytokine Storms and Fungal Co‐Infections via Docking and Simulation

Journal of Cellular and Molecular Medicine, Volume 29, Issue 21, November 2025.
ABSTRACT Severe COVID‐19 cases are often characterised by a hyperinflammatory cytokine storm, which leads to immune dysregulation and increased mortality. Simultaneously, opportunistic fungal infections such as mucormycosis have been increasingly reported, especially in immunocompromised individuals.
Hailah M. Almohaimeed, Aniruddha Chatterjee, Majedah Ramadan Alaqabawi, Fayez Alsulaimani, Ahmed M. Basri, Ayman Jafer, Abdullah F. Shater, Fayez M. Saleh, Bikram Dhara, Daniel Ejim Uti, Esther Ugo Alum   +10 more
wiley   +1 more source

Hepatic mucormycosis in a child with fulminant hepatic failure

The Turkish Journal of Pediatrics, 1996
Mucormycosis is an uncommon, opportunistic infection in children. We present a case of fulminant hepatic failure with hepatic mucormycosis. Although the suggested defects and pathogenic mechanisms in infections related to hepatic failure and ...
G Erdem, M Cağlar, M Ceyhan, Z Akçören, G Kanra   +4 more
doaj  

Nasosinusal Mucormycosis - Clinical Reports and Literature Review [PDF]

, 2011
A mucormicose e uma infecção fúngica potencialmente grave,causada por fungo saprófita. Pode tornar-se patogénico, em condições específicas, com evolução frequentemente fatal, particularmente em indivíduos imunocomprometidos.
Amaro, C, Barros, E, Casas Novas, A, Montemor, R, Ribeiro, C, Ribeiro, S   +5 more
core  

The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis

Transplant Infectious Disease, Volume 27, Issue 6, November/December 2025.
This single‐center retrospective cohort study on 300 allogeneic hematopoietic stem cell transplant recipients from January 2017 to May 2020, in which posaconazole modified release was the most common primary antifungal prophylaxis, demonstrated a breakthrough invasive fungal disease (bIFD) rate of 9%, with associated significant all‐cause mortality at ...
Shio Yen Tio, Chin Fen Neoh, David Ritchie, Lynette Chee, David C. M. Kong, Leon J. Worth, Michelle K. Yong, Monica A. Slavin   +7 more
wiley   +1 more source